These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30638075)

  • 21. Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease.
    Buades-Reinés J; Raya-Cruz M; Gallego-Lezaún C; Ripoll-Vera T; Usón-Martín M; Andreu-Serra H; Cisneros-Barroso E
    J Peripher Nerv Syst; 2016 Dec; 21(4):352-356. PubMed ID: 27403623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
    Schmidt HH; Barroso F; González-Duarte A; Conceição I; Obici L; Keohane D; Amass L
    Muscle Nerve; 2016 Sep; 54(3):353-60. PubMed ID: 27273296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy].
    Sekijima Y
    Rinsho Shinkeigaku; 2014; 54(12):953-6. PubMed ID: 25672679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical variant of familial amyloid polyneuropathy.
    Quan D; Cohen JA
    Muscle Nerve; 2002 Sep; 26(3):417-20. PubMed ID: 12210373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients.
    Moshe-Lilie O; Dimitrova D; Heitner SB; Brannagan TH; Zivkovic S; Hanna M; Masri A; Polydefkis M; Berk JL; Gertz MA; Karam C
    Amyloid; 2020 Dec; 27(4):250-253. PubMed ID: 32578459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
    Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y
    Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.
    Inês M; Coelho T; Conceição I; Ferreira L; de Carvalho M; Costa J
    Orphanet J Rare Dis; 2020 Mar; 15(1):67. PubMed ID: 32143656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early diagnosis and management of patients with familial ATTR amyloidosis receiving livers from asymptomatic variant TTR carriers.
    Munar-Qués M; Viader-Farré C; Zabay-Becerril JM; Mulet-Ferrer JM
    Amyloid; 2011 Sep; 18(3):172-3. PubMed ID: 21774739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin Amyloidosis.
    Yu RZ; Collins JW; Hall S; Ackermann EJ; Geary RS; Monia BP; Henry SP; Wang Y
    Nucleic Acid Ther; 2020 Jun; 30(3):153-163. PubMed ID: 32286934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
    Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
    Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validating the usefulness of Sudoscan in ATTRv: a single centre experience.
    Moreno-Moraleda E; González-Moreno J; Cisneros-Barroso E; Ribot-Sansó MA; Ripoll-Vera T; Descals C; Uson M; Montalà JC; Figuerola A; Rodríguez A; Losada I
    Neurol Sci; 2024 Jun; 45(6):2859-2867. PubMed ID: 38261153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study.
    Galán Dávila L; Martinez Valle F; Buades Reinés J; Gonzalez-Moreno J; Losada López I; Sevilla T; Muñoz Beamud F; Bárcena Llona JE; Romero Acebal M; Setaro F; Primiano D; Tarilonte P
    Orphanet J Rare Dis; 2024 Sep; 19(1):323. PubMed ID: 39242501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.
    Waddington-Cruz M; Ackermann EJ; Polydefkis M; Heitner SB; Dyck PJ; Barroso FA; Wang AK; Berk JL; Dyck PJB; Monia BP; Hughes SG; Tai L; Jesse Kwoh T; Jung SW; Coelho T; Benson MD; Gertz MA
    Amyloid; 2018 Sep; 25(3):180-188. PubMed ID: 30169969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathy Associated with Systemic Amyloidosis.
    Kaku M; Berk JL
    Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area.
    Takahashi R; Ono K; Shibata S; Nakamura K; Komatsu J; Ikeda Y; Ikeda T; Samuraki M; Sakai K; Iwasa K; Kayano D; Yamada M
    J Neurol Sci; 2014 Oct; 345(1-2):231-5. PubMed ID: 25060417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.